Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06986967 · ClinicalTrials.gov registry record · NA

Retrograde Versus Antegrade Perfusion in Low-Moderate Hypothermia for Aortic Arch Surgery

A NA study of Brain Function and Hemiarch Cardiac Procedure, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
2
Study locations

NCT06986967 is a NA study of Brain Function and Hemiarch Cardiac Procedure that is actively recruiting participants, run by Duke University. The registered enrollment target is 30 participants, below the 315-participant average among 3 other Brain Function trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06986967, a NA study of Brain Function and Hemiarch Cardiac Procedure, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to compare brain function after surgical circulatory arrest using either antegrade perfusion or retrograde perfusion.

Interventions

  • PROCEDURE Antegrade Perfusion
  • PROCEDURE Retrograde Perfusion

Study Locations (2)

North Carolina

  • Duke Univeristy - Durham
  • Duke Univeristy - Durham

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-04-18
Est. Completion 2027-03
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT06986967

The ClinicalTrials.gov registry entry for NCT06986967 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 315-participant average among 3 other Brain Function trials with a reported enrollment target (90% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Brain Function appearing as the primary indexed condition, and to 2 interventions - of which Antegrade Perfusion is the first listed.

NCT06986967 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06986967 about?

NCT06986967 is a clinical study titled "Retrograde Versus Antegrade Perfusion in Low-Moderate Hypothermia for Aortic Arch Surgery". The purpose of this study is to compare brain function after surgical circulatory arrest using either antegrade perfusion or retrograde perfusion.

What is the current status of trial NCT06986967?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-04-18. Estimated completion is 2027-03.

What conditions does trial NCT06986967 study?

This clinical trial studies the following conditions: Brain Function, Hemiarch Cardiac Procedure.

What interventions are being tested in trial NCT06986967?

The interventions under investigation include: Antegrade Perfusion (PROCEDURE), Retrograde Perfusion (PROCEDURE).

Who is sponsoring clinical trial NCT06986967?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06986967 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Function

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.